Skip to main content

Do Vaccines Cause Narcolepsy?

  • Chapter
  • First Online:
The Clinician’s Vaccine Safety Resource Guide

Abstract

The AS03-adjuvanted 2009 pandemic H1N1 influenza vaccine (trade name: PandemrixTM) was associated with an increased risk of narcolepsy in several northern European countries. In other countries where there is a lower prevalence of genetic factors associated with narcolepsy, studies did not find an increase in risk with this vaccine or other influenza vaccines. The vaccine in question (PandemrixTM) was not licensed in the United States, and vaccines in routine use in the United States32F have not been shown to cause narcolepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    These conclusions do not consider vaccines recommended only for special populations in the United States such as Yellow Fever vaccine (international travelers) or Smallpox vaccine (military personnel).

References

  1. Nohynek, H., et al., AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One, 2012. 7(3): p. e33536.

    Article  CAS  Google Scholar 

  2. Partinen, M., et al., Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One, 2012. 7(3): p. e33723.

    Article  CAS  Google Scholar 

  3. Szakacs, A., N. Darin, and T. Hallbook, Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology, 2013. 80(14): p. 1315–21.

    Article  Google Scholar 

  4. Persson, I., et al., Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med, 2014. 275(2): p. 172–90.

    Article  CAS  Google Scholar 

  5. Johansen, K., The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation. Dev Med Child Neurol, 2014. 56(11): p. 1041–2.

    Article  Google Scholar 

  6. Dauvilliers, Y., et al., Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain, 2013. 136(Pt 8): p. 2486–96.

    Article  Google Scholar 

  7. Wijnans, L., et al., The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine, 2013. 31(8): p. 1246–54.

    Article  Google Scholar 

  8. European Centre for Disease Prevention and Control, Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation). ECDC: Stockholm.

    Google Scholar 

  9. Miller, E., et al., Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. Bmj, 2013. 346: p. f794.

    Article  Google Scholar 

  10. O’Flanagan, D., et al., Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill, 2014. 19(17): p. 15–25.

    Article  Google Scholar 

  11. Stowe, J., et al., Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Sleep, 2016. 39(5): p. 1051–7.

    Article  Google Scholar 

  12. Heier, M.S., et al., Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med, 2013. 14(9): p. 867–71.

    Article  CAS  Google Scholar 

  13. Oberle, D., et al., Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany. Sleep Med, 2017. 34: p. 71–83.

    Article  Google Scholar 

  14. Feltelius, N., et al., A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009–2010 Pandemrix vaccination programme in Sweden. J Intern Med, 2015. 278(4): p. 335–53.

    Article  CAS  Google Scholar 

  15. Montplaisir, J., et al., Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One, 2014. 9(9): p. e108489.

    Article  Google Scholar 

  16. Partinen, M., et al., Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol, 2014. 13(6): p. 600–13.

    Article  CAS  Google Scholar 

  17. McCarthy, N.L., et al., Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine, 2013. 31(50): p. 5975–82.

    Article  Google Scholar 

  18. Tsai, T.F., et al., Explorations of clinical trials and pharmacovigilance databases of MF59(R)-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand J Infect Dis, 2011. 43(9): p. 702–6.

    Article  CAS  Google Scholar 

  19. Ahmed, S.S., et al., Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun, 2014. 50: p. 1–11.

    Article  CAS  Google Scholar 

  20. Duffy, J., et al., Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology, 2014. 83(20): p. 1823–30.

    Article  CAS  Google Scholar 

  21. Baxter, R., et al., Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years. Vaccine, 2017. 35(9): p. 1254–8.

    Article  CAS  Google Scholar 

  22. Arnheim-Dahlström, L., et al., Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ : British Medical Journal, 2013. 347.

    Article  Google Scholar 

  23. Sarkanen, T.O., et al., Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med Rev, 2018. 38: p. 177–86.

    Article  Google Scholar 

  24. Han, F., et al., Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol, 2011. 70(3): p. 410–7.

    Article  Google Scholar 

  25. Matsuki, K., et al., DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet, 1992. 339(8800): p. 1052.

    Article  CAS  Google Scholar 

  26. Kadotani, H., J. Faraco, and E. Mignot, Genetic studies in the sleep disorder narcolepsy. Genome Res, 1998. 8(5): p. 427–34.

    Article  CAS  Google Scholar 

  27. Dye, T.J., N. Gurbani, and N. Simakajornboon, Epidemiology and Pathophysiology of Childhood Narcolepsy. Paediatr Respir Rev, 2016.

    Google Scholar 

  28. Johansen, K., et al., Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines? Biologicals, 2016. 44(4): p. 276–80.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dudley, M.Z. et al. (2018). Do Vaccines Cause Narcolepsy?. In: The Clinician’s Vaccine Safety Resource Guide. Springer, Cham. https://doi.org/10.1007/978-3-319-94694-8_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94694-8_46

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94693-1

  • Online ISBN: 978-3-319-94694-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics